Literature DB >> 30113768

Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.

Paras H Shah1, Timothy D Lyon1, Christine M Lohse2, John C Cheville3, Bradley C Leibovich1, Stephen A Boorjian1, R Houston Thompson1.   

Abstract

OBJECTIVE: To investigate the prognostic significance of various patterns of extrarenal extension that comprise pathological stage T3a clear-cell renal cell carcinoma (ccRCC) amongst patients undergoing nephrectomy for non-metastatic disease. PATIENTS AND METHODS: A retrospective review of 563 patients who underwent radical nephrectomy for pathologically confirmed T3aN0/NxM0 ccRCC between 1970 and 2011 was performed. All pathological slides were re-reviewed by one urological pathologist. Associations of patterns of extrarenal extension (perinephric fat [PF], renal sinus fat [SF], and renal vein [RV], in isolation or in any combination) with disease progression, cancer-specific mortality (CSM), and all-cause mortality were evaluated on multivariable analyses.
RESULTS: Overall, PF invasion, renal SF invasion, and RV tumour thrombus were present in 144 (26%), 51 (9%), and 163 (29%) patients, respectively, with multiple patterns of extrarenal extension identified in 205 (36%) patients. There were no significant differences in survival outcomes for isolated involvement of PF, renal SF, or RV. However, patients with multiple patterns of extrarenal extension were at significantly increased risk of disease progression (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.04-1.65; P = 0.020), CSM (HR 1.64, 95% CI 1.27-2.12; P < 0.001), and all-cause mortality (HR 1.32, 95% CI 1.08-1.61; P = 0.008).
CONCLUSIONS: The presence of multiple patterns of extrarenal extension is associated with a higher risk of disease progression and cancer-related death after radical nephrectomy compared to isolated involvement of the PF, renal SF, or RV, which carry similar prognostic weight. If validated, these findings may help refine risk stratification of non-metastatic T3a RCC by distinguishing patients with multiple vs one pattern of extrarenal extension.
© 2018 The Authors BJU International © 2018 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  neoplasm staging; nephrectomy; renal cell carcinoma

Mesh:

Year:  2018        PMID: 30113768     DOI: 10.1111/bju.14523

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  11 in total

1.  Pathologic T3a renal cell carcinoma: a classification in need of further refinement.

Authors:  John M DiBianco; Patrick T Gomella; Mark W Ball
Journal:  Ann Transl Med       Date:  2018-12

2.  Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.

Authors:  Takashi Yoshida; Chisato Ohe; Toyonori Tsuzuki; Motohiko Sugi; Hidefumi Kinoshita; Koji Tsuta; Tadashi Matsuda
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

3.  Prognostic Evaluation of the Site of Invasion in Pathological Stage T3a Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

4.  The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.

Authors:  Luping Li; Lei Shi; Junjie Zhang; Yingzhong Fan; Qi Li
Journal:  Cancer Med       Date:  2020-12-06       Impact factor: 4.452

5.  Association of Extrarenal Invasion Patterns and Tumor Size with the Differences in Survival Outcomes of T3a Renal Cell Carcinoma: A Proposal Modified T3a Stage System is Needed.

Authors:  XiaoFei Wu; Qiong Wang; Zhixian Wang; Xian Zhao; XiaoJing Xu
Journal:  Int J Gen Med       Date:  2022-01-07

Review 6.  Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Authors:  Kalle E Mattila; Paula Vainio; Panu M Jaakkola
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

7.  Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.

Authors:  Shiliang Liu; Chunxiang Feng; Chang Liu; Zhixian Wang
Journal:  Cancer Med       Date:  2021-11-14       Impact factor: 4.452

8.  Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management.

Authors:  Ricardo G Alvim; Amy L Tin; Lucas Nogueira; Nathan C Wong; Renato C Fonseca; Daniel D Sjoberg; A Ari Hakimi; Karim A Touijer; Paul Russo; Jonathan A Coleman
Journal:  Urology       Date:  2021-07-29       Impact factor: 2.649

9.  Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis.

Authors:  Pengju Guo; Yongxing Wang; Yili Han; Dechao Wei; Jiahui Zhao; Mingchuan Li; Yongguang Jiang; Yong Luo
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

10.  The prognostic value of fat invasion and tumor expansion in the hilar veins in pT3a renal cell carcinoma.

Authors:  Viktoria Stühler; Steffen Rausch; Katharina Kroll; Marcus Scharpf; Arnulf Stenzl; Jens Bedke
Journal:  World J Urol       Date:  2021-02-27       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.